Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractExhaled volatile organic compounds in adult asthma: a systematic review    Next AbstractEmissions of Ultrafine Particles and Volatile Organic Compounds from Commercially Available Desktop Three-Dimensional Printers with Multiple Filaments »

J Pers Med


Title:Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma
Author(s):Azim A; Rezwan FI; Barber C; Harvey M; Kurukulaaratchy RJ; Holloway JW; Howarth PH;
Address:"Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton SO16 6YD, UK. Department of Computer Science, Aberystwyth University, Aberystwyth SY23 3DB, UK. Human Development and Health, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. David Hide Asthma and Allergy Research Centre, Isle of Wight NHS Trust, Newport PO30 5TG, UK"
Journal Title:J Pers Med
Year:2022
Volume:20221002
Issue:10
Page Number: -
DOI: 10.3390/jpm12101635
ISSN/ISBN:2075-4426 (Print) 2075-4426 (Electronic) 2075-4426 (Linking)
Abstract:"The measurement of exhaled volatile organic compounds (VOCs) in exhaled breath (breathomics) represents an exciting biomarker matrix for airways disease, with early research indicating a sensitivity to airway inflammation. One of the key aspects to analytical validity for any clinical biomarker is an understanding of the short-term repeatability of measures. We collected exhaled breath samples on 5 consecutive days in 14 subjects with severe asthma who had undergone extensive clinical characterisation. Principal component analysis on VOC abundance across all breath samples revealed no variance due to the day of sampling. Samples from the same patients clustered together and there was some separation according to T2 inflammatory markers. The intra-subject and between-subject variability of each VOC was calculated across the 70 samples and identified 30.35% of VOCs to be erratic: variable between subjects but also variable in the same subject. Exclusion of these erratic VOCs from machine learning approaches revealed no apparent loss of structure to the underlying data or loss of relationship with salient clinical characteristics. Moreover, cluster evaluation by the silhouette coefficient indicates more distinct clustering. We are able to describe the short-term repeatability of breath samples in a severe asthma population and corroborate its sensitivity to airway inflammation. We also describe a novel variance-based feature selection tool that, when applied to larger clinical studies, could improve machine learning model predictions"
Keywords:Voc asthma breathomics repeatability respiratory severe asthma volatile organic compounds;
Notes:"PubMed-not-MEDLINEAzim, Adnan Rezwan, Faisal I Barber, Clair Harvey, Matthew Kurukulaaratchy, Ramesh J Holloway, John W Howarth, Peter H eng Switzerland 2022/10/28 J Pers Med. 2022 Oct 2; 12(10):1635. doi: 10.3390/jpm12101635"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 27-12-2024